AI Bot Assists Doctors in Patient Care

A specialized medical chatbot developed by Google, known as AMIE (Articulate Medical Intelligence Explorer), has shown promise in assisting primary care physicians. In a recent eight-month clinical trial involving nearly 100 patients at Beth Israel Deaconess Medical Center, physicians reported that the AI was helpful in approximately 75 percent of cases. This technology, powered by Google's Gemini AI, may have influenced the management of more than half of those cases. Doctors likened the bot's performance to that of a capable medical student or resident. The study, published in The Lancet, highlighted the AI's high accuracy, with only one instance of "hallucination"—making up information—reported across hundreds of patient conversations. During the trial, trained physicians monitored the AI, ready to intervene, but no conversations required halting. They did, however, provide additional context to patients on five occasions, such as reassuring a patient when cancer was listed as a potential diagnosis. Patient trust in the chatbot was found to be dependent on the presence and oversight of human doctors. This trial is part of a broader effort to integrate AI into healthcare, with Google currently conducting a nationwide trial comparing patient visits with and without chatbots.